source Post navigation STRIDE: Semaglutide Improves Functional Outcomes in Peripheral Artery Disease – MD Magazine Ozempic® (once-weekly semaglutide 1.0 mg) shown to improve walking distance and quality of life in adults with type 2 diabetes and peripheral artery disease (PAD) at ACC 2025 – Yahoo Finance